Overview
Pilot Study of Epoetin Alfa for Patients Having Abdominal or Pelvic Surgery for Cancer
Status:
Completed
Completed
Trial end date:
2008-12-01
2008-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This pilot study is looking at how well epoetin alfa, given in the immediate post-operative period, works in reducing anemia and the need for transfusions.Phase:
Phase 1Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
University of FloridaCollaborator:
Ortho Biotech Clinical Affairs, L.L.C.Treatments:
Epoetin Alfa
Criteria
Inclusion Criteria:- Patients undergoing esophagectomy, gastrectomy, partial pancreatectomy, hepatic
resection, or low anterior resection of rectum for malignancy
- Patients with hemoglobin greater than 8 and less than 11 g/dL on post-operative day
#1.
Exclusion Criteria:
- Patients receiving red blood cell transfusion within the first twelve hours
post-operatively.
- Patients receiving epoetin-stimulating proteins within 30 days prior to the operation.